GSK chases Astra with start of big anaemia drug trials

LONDON, Nov 24 (Reuters) - GlaxoSmithKline has

started pivotal trials of an experimental anaemia drug, chasing

AstraZeneca in the race to develop a medicine that

mimics the body's response to high...

Read more